Endogenous type I interferons as a defense against tumors
- 15 March 2002
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 13 (2) , 111-118
- https://doi.org/10.1016/s1359-6101(01)00035-1
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The neglected role of type I interferon in the T-cell response: implications for its clinical useImmunology Today, 1996
- Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in VivoScience, 1996
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994
- Importance of interferon α in the resistance of allogeneic C57B1/6 mice to the multiplication of friend erythroleukemia cells in the liverInternational Journal of Cancer, 1990
- Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in MiceJNCI Journal of the National Cancer Institute, 1989
- Transplantation ImmunologyNew England Journal of Medicine, 1987
- The physiological interferon responseImmunology Today, 1985
- Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.The Journal of Experimental Medicine, 1984
- Interferon inhibits the generation of allospecific suppressor T lymphocytes.The Journal of Experimental Medicine, 1982
- PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONSBiological Reviews, 1981